Harrington Investments, Inc Abb Vie Inc. Transaction History

Harrington Investments, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $33,086 - $40,804	-425 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$88.91 - $98.84 $13,336 - $14,826	150 Added 54.55%	425 $40,000
Q1 2018 Apr 12, 2018	BUY	$92.01 - $123.21 $25,302 - $33,882	275 New	275 $26,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Harrington Investments, Inc, based on Form 13F filings with the SEC.

Stay updated on Harrington Investments, Inc with notifications on news.